<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
	<channel>
		<title>Horses News -- ScienceDaily</title>
		<link>https://www.sciencedaily.com/news/plants_animals/horses/</link>
		<description>Equine News. All about horses including the latest in horse cloning, race horse physiology and horse health.</description>
		<language>en-us</language>
		<pubDate>Thu, 05 Mar 2026 01:19:44 EST</pubDate>
		<lastBuildDate>Thu, 05 Mar 2026 01:19:44 EST</lastBuildDate>
		<ttl>60</ttl>
		<image>
			<title>Horses News -- ScienceDaily</title>
			<url>https://www.sciencedaily.com/images/scidaily-logo-rss.png</url>
			<link>https://www.sciencedaily.com/news/plants_animals/horses/</link>
			<description>For more science news, visit ScienceDaily.</description>
		</image>
		<atom:link xmlns:atom="http://www.w3.org/2005/Atom" rel="self" href="https://www.sciencedaily.com/rss/plants_animals/horses.xml" type="application/rss+xml" />
		<item>
			<title>Scientists finally solve the mystery of the horse whinny</title>
			<link>https://www.sciencedaily.com/releases/2026/02/260225001256.htm</link>
			<description>Horses have a vocal trick no one fully understood until now. Scientists have discovered that when a horse whinnies, it produces two completely different sounds at the same time. One is a deep tone created by vibrating the vocal folds, similar to how humans sing. The other is a high-pitched whistle generated inside the larynx, something never before confirmed in a large mammal. This rare ability, known as biphonation, likely helps horses send multiple emotional signals in a single call.</description>
			<pubDate>Wed, 25 Feb 2026 04:01:40 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2026/02/260225001256.htm</guid>
		</item>
		<item>
			<title>Bird flu’s surprising heat tolerance has scientists worried</title>
			<link>https://www.sciencedaily.com/releases/2025/11/251128050503.htm</link>
			<description>Researchers discovered why bird flu can survive temperatures that stop human flu in its tracks. A key gene, PB1, gives avian viruses the ability to replicate even at fever-level heat. Mice experiments confirmed that fever cripples human-origin flu but not avian strains, especially those with avian-like PB1. These findings highlight how gene swapping could fuel future pandemics.</description>
			<pubDate>Fri, 28 Nov 2025 07:37:38 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/11/251128050503.htm</guid>
		</item>
		<item>
			<title>They’re smaller than dust, but crucial for Earth’s climate</title>
			<link>https://www.sciencedaily.com/releases/2025/10/251010091548.htm</link>
			<description>Coccolithophores, tiny planktonic architects of Earth’s climate, capture carbon, produce oxygen, and leave behind geological records that chronicle our planet’s history. European scientists are uniting to honor them with International Coccolithophore Day on October 10. Their global collaboration highlights groundbreaking research into how these microscopic organisms link ocean chemistry, climate regulation, and carbon storage. The initiative aims to raise awareness that even the smallest ocean dwellers have planetary impact.</description>
			<pubDate>Fri, 10 Oct 2025 09:54:52 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/10/251010091548.htm</guid>
		</item>
		<item>
			<title>Horses &#039;mane&#039; inspiration for new generation of social robots</title>
			<link>https://www.sciencedaily.com/releases/2025/05/250528214222.htm</link>
			<description>Interactive robots should not just be passive companions, but active partners -- like therapy horses who respond to human emotion -- say researchers.</description>
			<pubDate>Wed, 28 May 2025 21:42:22 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/05/250528214222.htm</guid>
		</item>
		<item>
			<title>HIV vaccine study uncovers powerful new antibody target</title>
			<link>https://www.sciencedaily.com/releases/2025/05/250527124123.htm</link>
			<description>In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies capable of blocking a wide range of HIV strains -- including those that are typically the hardest to stop.</description>
			<pubDate>Tue, 27 May 2025 12:41:23 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/05/250527124123.htm</guid>
		</item>
		<item>
			<title>Engineered bacteria can deliver antiviral therapies, vaccines</title>
			<link>https://www.sciencedaily.com/releases/2025/05/250521124626.htm</link>
			<description>New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.</description>
			<pubDate>Wed, 21 May 2025 12:46:26 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/05/250521124626.htm</guid>
		</item>
		<item>
			<title>Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies</title>
			<link>https://www.sciencedaily.com/releases/2025/05/250515145628.htm</link>
			<description>A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional approaches haven&#039;t worked -- largely because HIV mutates rapidly and hides key parts of itself from the immune system. Now, a new study combining data from two separate phase 1 clinical trials shows that a targeted vaccine strategy can successfully activate early immune responses relevant to HIV, and, in one trial, further advance them -- a key step toward a long-sought goal in vaccine development.</description>
			<pubDate>Thu, 15 May 2025 14:56:28 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/05/250515145628.htm</guid>
		</item>
		<item>
			<title>Novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes</title>
			<link>https://www.sciencedaily.com/releases/2025/05/250509122258.htm</link>
			<description>A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop universal influenza vaccines that induce a more robust immune response against various virus subtypes, including both human and avian strains.</description>
			<pubDate>Fri, 09 May 2025 12:22:58 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/05/250509122258.htm</guid>
		</item>
		<item>
			<title>Engineering an antibody against flu with sticky staying power</title>
			<link>https://www.sciencedaily.com/releases/2025/05/250508112429.htm</link>
			<description>Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the broad binding capacity of a more general immune system defender.</description>
			<pubDate>Thu, 08 May 2025 11:24:29 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/05/250508112429.htm</guid>
		</item>
		<item>
			<title>Viruses under the super microscope: How influenza viruses communicate with cells</title>
			<link>https://www.sciencedaily.com/releases/2025/05/250507130605.htm</link>
			<description>Influenza viruses are among the most likely triggers of future pandemics. A research team has developed a method that can be used to study the interaction of viruses with host cells in unprecedented detail. With the help of their new development, they have also analyzed how novel influenza viruses use alternative receptors to enter target cells.</description>
			<pubDate>Wed, 07 May 2025 13:06:05 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/05/250507130605.htm</guid>
		</item>
		<item>
			<title>Antivenom neutralizes the neurotoxins of 19 of the world&#039;s deadliest snakes</title>
			<link>https://www.sciencedaily.com/releases/2025/05/250502133806.htm</link>
			<description>By using antibodies from a human donor with a self-induced hyper-immunity to snake venom, scientists have developed the most broadly effective antivenom to date, which is protective against the likes of the black mamba, king cobra, and tiger snakes in mouse trials. The antivenom combines protective antibodies and a small molecule inhibitor and opens a path toward a universal antiserum.</description>
			<pubDate>Fri, 02 May 2025 13:38:06 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/05/250502133806.htm</guid>
		</item>
		<item>
			<title>Updated equestrian helmet ratings system adds racing and high-speed events</title>
			<link>https://www.sciencedaily.com/releases/2025/04/250428220917.htm</link>
			<description>Falling off a horse at high-speed changes the impact to the rider&#039;s head and the parameters for a quality helmet, according to new research. The findings indicate that head impacts during falls at high speed generate unique head rotation, which in turn, directly affects helmet behavior.</description>
			<pubDate>Mon, 28 Apr 2025 22:09:17 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/04/250428220917.htm</guid>
		</item>
		<item>
			<title>Single-dose baloxavir reduces household influenza transmission</title>
			<link>https://www.sciencedaily.com/releases/2025/04/250425113801.htm</link>
			<description>A landmark study reveals that a single oral dose of baloxavir marboxil (baloxavir) significantly reduces the transmission of influenza within households, marking a major advancement in influenza management. The trial provides robust evidence that an antiviral treatment can curb the spread of influenza to close contacts.</description>
			<pubDate>Fri, 25 Apr 2025 11:38:01 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/04/250425113801.htm</guid>
		</item>
		<item>
			<title>How bacteria in our aging guts can elevate risk of leukemia and perhaps more</title>
			<link>https://www.sciencedaily.com/releases/2025/04/250423120659.htm</link>
			<description>Scientists have discovered a surprising new connection between gut health and blood cancer risk one that could transform how we think about aging, inflammation, and the early stages of leukemia.</description>
			<pubDate>Wed, 23 Apr 2025 12:06:59 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/04/250423120659.htm</guid>
		</item>
		<item>
			<title>Study reveals gaps in flu treatment for high-risk adults</title>
			<link>https://www.sciencedaily.com/releases/2025/04/250422131245.htm</link>
			<description>A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers found that only slightly more than half of these patients received antiviral prescriptions, and of those, only 80 percent were filled. This gap in treatment could increase the risk of severe flu complications, particularly for older adults and those with underlying conditions.</description>
			<pubDate>Tue, 22 Apr 2025 13:12:45 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/04/250422131245.htm</guid>
		</item>
		<item>
			<title>Nasal spray H5N1 avian influenza vaccine developed</title>
			<link>https://www.sciencedaily.com/releases/2025/04/250408122112.htm</link>
			<description>Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform enabled the rapid development of a nasal spray vaccine in collaboration with mainland China&#039;s Wantai BioPharm. After completing Phase 1-3 clinical trials, it was approved in 2022 as the world&#039;s first nasal spray COVID-19 vaccine.</description>
			<pubDate>Tue, 08 Apr 2025 12:21:12 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/04/250408122112.htm</guid>
		</item>
		<item>
			<title>How a small number of mutations can fuel outbreaks of western equine encephalitis virus</title>
			<link>https://www.sciencedaily.com/releases/2025/04/250404122422.htm</link>
			<description>New research shows how small shifts in the molecular makeup of a virus can profoundly alter its fate. These shifts could turn a deadly pathogen into a harmless bug or supercharge a relatively benign virus, influencing its ability to infect humans and cause dangerous outbreaks.</description>
			<pubDate>Fri, 04 Apr 2025 12:24:22 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/04/250404122422.htm</guid>
		</item>
		<item>
			<title>Corpse flowers are threatened by spotty recordkeeping</title>
			<link>https://www.sciencedaily.com/releases/2025/04/250403122948.htm</link>
			<description>Plant biologists examined records for nearly 1,200 individual corpse flower plants from 111 institutions around the world. The data and records were severely lacking and not standardized. Without complete information, conservationists were unable to make informed decisions about breeding their plants. Out of the plants studied, 24% were clones and 27% were offspring from closely related individuals. Low genetic diversity could lead to further endangerment and even extinction.</description>
			<pubDate>Thu, 03 Apr 2025 12:29:48 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/04/250403122948.htm</guid>
		</item>
		<item>
			<title>Engineering antibodies with a novel fusion protein</title>
			<link>https://www.sciencedaily.com/releases/2025/03/250325160113.htm</link>
			<description>Even with significant expansion in the global market for antibodies used in clinical care and research, scientists recognize that there is still untapped potential for finding new antibodies. Many proteins group together in what are called protein complexes to carry out biological functions. The traditional method of generating antibodies by immunizing animals struggles to make antibodies related to these protein complexes. Scientists have now demonstrated that fusing protein complexes together adds stability during immunization and enables antibody generation.</description>
			<pubDate>Tue, 25 Mar 2025 16:01:13 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/03/250325160113.htm</guid>
		</item>
		<item>
			<title>New mechanism behind adaptive immunity revealed: It could impact how we design vaccines</title>
			<link>https://www.sciencedaily.com/releases/2025/03/250319142835.htm</link>
			<description>New imaging reveals a built-in safeguard that allows B cell populations to rapidly expand in germinal centers without introducing deleterious mutations.</description>
			<pubDate>Wed, 19 Mar 2025 14:28:35 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/03/250319142835.htm</guid>
		</item>
		<item>
			<title>Efficient development of drugs with fewer mice</title>
			<link>https://www.sciencedaily.com/releases/2025/03/250318141555.htm</link>
			<description>New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies simultaneously in a single mouse. This should not only speed up the research and development pipeline for new drugs, but also hugely reduce the number of laboratory animals required.</description>
			<pubDate>Tue, 18 Mar 2025 14:15:55 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/03/250318141555.htm</guid>
		</item>
		<item>
			<title>Older adults might be more resistant to bird flu infections than children</title>
			<link>https://www.sciencedaily.com/releases/2025/03/250313180452.htm</link>
			<description>Older adults who were exposed to seasonal flu viruses that circulated prior to 1968 are more likely to have some protection against H5N1, and children would benefit more from H5N1 vaccines.</description>
			<pubDate>Thu, 13 Mar 2025 18:04:52 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/03/250313180452.htm</guid>
		</item>
		<item>
			<title>New discovery to accelerate Strep A vaccine efforts</title>
			<link>https://www.sciencedaily.com/releases/2025/03/250306121242.htm</link>
			<description>Researchers have discovered how antibodies help to protect against contagious bacterial infections caused by Strep A, including strep throat. And the findings are already contributing to efforts to accelerate the development of a Strep A vaccine.</description>
			<pubDate>Thu, 06 Mar 2025 12:12:42 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/03/250306121242.htm</guid>
		</item>
		<item>
			<title>New antibodies show potential to defeat all SARS-CoV-2 variants</title>
			<link>https://www.sciencedaily.com/releases/2025/03/250305164351.htm</link>
			<description>A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the approach shows promise in developing treatments to keep pace with evolving viruses.</description>
			<pubDate>Wed, 05 Mar 2025 16:43:51 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/03/250305164351.htm</guid>
		</item>
		<item>
			<title>Research identifies key antibodies for development of broadly protective norovirus vaccine</title>
			<link>https://www.sciencedaily.com/releases/2025/03/250305164340.htm</link>
			<description>Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies for the treatment of norovirus-associated gastroenteritis.</description>
			<pubDate>Wed, 05 Mar 2025 16:43:40 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/03/250305164340.htm</guid>
		</item>
		<item>
			<title>Giant clone of seaweed in the Baltic Sea</title>
			<link>https://www.sciencedaily.com/releases/2025/03/250304114321.htm</link>
			<description>Researchers have discovered that what was previously thought to be a unique seaweed species of bladderwrack for the Baltic Sea is in fact a giant clone of common bladderwrack, perhaps the world&#039;s largest clone overall. The discovery has implications for predicting the future of seaweed in a changing ocean.</description>
			<pubDate>Tue, 04 Mar 2025 11:43:21 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/03/250304114321.htm</guid>
		</item>
		<item>
			<title>Underwater fossil bed discovered by collectors preserves rare slice of Florida&#039;s past</title>
			<link>https://www.sciencedaily.com/releases/2025/02/250212134838.htm</link>
			<description>Fossil collectors in Florida have discovered an ancient sinkhole, now at the bottom of a river, which holds the remains of animals rarely seen in the state, including a type of giant armadillo, giant ground sloths and an odd-looking tapir.</description>
			<pubDate>Wed, 12 Feb 2025 13:48:38 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/02/250212134838.htm</guid>
		</item>
		<item>
			<title>Influenza A viruses adapt shape in response to environmental pressures</title>
			<link>https://www.sciencedaily.com/releases/2025/02/250210153934.htm</link>
			<description>Influenza A virus particles strategically adapt their shape -- to become either spheres or larger filaments -- to favor their ability to infect cells depending on environmental conditions, according to a new study. This previously unrecognized response could help explain how influenza A and other viruses persist in populations, evade immune responses, and acquire adaptive mutations, the researchers explain.</description>
			<pubDate>Mon, 10 Feb 2025 15:39:34 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/02/250210153934.htm</guid>
		</item>
		<item>
			<title>Antibody treatment prevents severe bird flu in monkeys</title>
			<link>https://www.sciencedaily.com/releases/2025/01/250130161626.htm</link>
			<description>The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.</description>
			<pubDate>Thu, 30 Jan 2025 16:16:26 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/01/250130161626.htm</guid>
		</item>
		<item>
			<title>New &#039;Matchless&#039; grass variety yields high seed count without need for field burning</title>
			<link>https://www.sciencedaily.com/releases/2025/01/250130140458.htm</link>
			<description>A new grass variety, &#039;Matchless,&#039; offers seed growers higher yields without the harmful impacts of burning. It also provides consumers with the option of a more environmentally friendly grass.</description>
			<pubDate>Thu, 30 Jan 2025 14:04:58 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/01/250130140458.htm</guid>
		</item>
		<item>
			<title>Protein labeling of tens of millions of densely packed cells in organ-scale tissues</title>
			<link>https://www.sciencedaily.com/releases/2025/01/250124151249.htm</link>
			<description>Tissue processing advance can label proteins at the level of individual cells across whole, intact rodent brains and other large samples just as fast and uniformly as in dissociated single cells.</description>
			<pubDate>Fri, 24 Jan 2025 15:12:49 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/01/250124151249.htm</guid>
		</item>
		<item>
			<title>A chain reaction: HIV vaccines can lead to antibodies against antibodies</title>
			<link>https://www.sciencedaily.com/releases/2025/01/250117161118.htm</link>
			<description>Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific virus, thereby providing protection. But scientists have now discovered that for some HIV vaccines, something else happens: after a few immunizations the immune system begins to produce antibodies against immune complexes already bound to the viral protein alone.</description>
			<pubDate>Fri, 17 Jan 2025 16:11:18 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/01/250117161118.htm</guid>
		</item>
		<item>
			<title>&#039;Perfect storm&#039; of mutations drives infection-triggered autoimmune disease</title>
			<link>https://www.sciencedaily.com/releases/2025/01/250115125110.htm</link>
			<description>Researchers have uncovered how chronic hepatitis C infection leads to autoimmune disease, which opens new paths for treatments</description>
			<pubDate>Wed, 15 Jan 2025 12:51:10 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/01/250115125110.htm</guid>
		</item>
		<item>
			<title>Two-in-one root armor protects plants from environmental stressors and fights climate change</title>
			<link>https://www.sciencedaily.com/releases/2025/01/250109125507.htm</link>
			<description>Scientists have created the first single cell genomic atlas of mature plants&#039; outer armor layer, called the periderm, and its carbon-capturing phellem cells. The findings will be useful in creating more robust, climate change-fighting plants.</description>
			<pubDate>Thu, 09 Jan 2025 12:55:07 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/01/250109125507.htm</guid>
		</item>
		<item>
			<title>Researchers discover class of anti-malaria antibodies</title>
			<link>https://www.sciencedaily.com/releases/2025/01/250103124926.htm</link>
			<description>Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.</description>
			<pubDate>Fri, 03 Jan 2025 12:49:26 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2025/01/250103124926.htm</guid>
		</item>
		<item>
			<title>People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination</title>
			<link>https://www.sciencedaily.com/releases/2024/12/241230131910.htm</link>
			<description>Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with normal immune function.</description>
			<pubDate>Mon, 30 Dec 2024 13:19:10 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/12/241230131910.htm</guid>
		</item>
		<item>
			<title>Scientists design workaround that improves response to flu vaccine</title>
			<link>https://www.sciencedaily.com/releases/2024/12/241219151655.htm</link>
			<description>Stitching together four molecules found in the standard flu vaccine ensures an immune response to all of them, scientists have shown.</description>
			<pubDate>Thu, 19 Dec 2024 15:16:55 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/12/241219151655.htm</guid>
		</item>
		<item>
			<title>Study shows drop in use of antiviral medications in young children with influenza</title>
			<link>https://www.sciencedaily.com/releases/2024/12/241217131104.htm</link>
			<description>Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an underuse of the treatment.</description>
			<pubDate>Tue, 17 Dec 2024 13:11:04 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/12/241217131104.htm</guid>
		</item>
		<item>
			<title>Staphylococcus aureus thwarts vaccines by turning on a protein that halts immune response</title>
			<link>https://www.sciencedaily.com/releases/2024/12/241216125632.htm</link>
			<description>After dozens of clinical trials, there are still no effective vaccines against Staphylococcus aureus. In two new studies, scientists report that the pathogen turns on the protein interleukin 10, shutting down the protective vaccine response. But blocking the protein restores vaccine efficacy in an animal model.</description>
			<pubDate>Mon, 16 Dec 2024 12:56:32 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/12/241216125632.htm</guid>
		</item>
		<item>
			<title>Flu virus remains infectious in refrigerated raw milk, study reveals</title>
			<link>https://www.sciencedaily.com/releases/2024/12/241213211312.htm</link>
			<description>Influenza or flu virus remains infectious in refrigerated raw milk for up to five days, according to a new study. The findings come at a time when outbreaks of bird flu -- a different subtype of the same influenza virus -- in dairy cattle have raised concerns about the potential for a new pandemic.</description>
			<pubDate>Fri, 13 Dec 2024 21:13:12 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/12/241213211312.htm</guid>
		</item>
		<item>
			<title>A lipid nanoparticle delivers mRNA cure for pre-eclampsia in mice</title>
			<link>https://www.sciencedaily.com/releases/2024/12/241211124503.htm</link>
			<description>Engineers have developed a lipid nanoparticle (LNP) that delivers mRNA therapeutic to the placenta to treat pre-eclampsia in mice with human trials on the horizon.</description>
			<pubDate>Wed, 11 Dec 2024 12:45:03 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/12/241211124503.htm</guid>
		</item>
		<item>
			<title>Scientists transform ubiquitous skin bacterium into a topical vaccine</title>
			<link>https://www.sciencedaily.com/releases/2024/12/241211124345.htm</link>
			<description>Scientists&#039; findings in mice could translate into a radical, needle-free vaccination approach that would also eliminate reactions including fever, swelling and pain.</description>
			<pubDate>Wed, 11 Dec 2024 12:43:45 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/12/241211124345.htm</guid>
		</item>
		<item>
			<title>Single mutation in H5N1 influenza surface protein could enable easier human infection</title>
			<link>https://www.sciencedaily.com/releases/2024/12/241206162110.htm</link>
			<description>A single modification in the protein found on the surface of the highly pathogenic avian influenza (HPAI) H5N1 influenza virus currently circulating in U.S. dairy cows could allow for easier transmission among humans, according to new research. The study results reinforce the need for continued, vigilant surveillance and monitoring of HPAI H5N1 for potential genetic changes that could make the virus more transmissible in humans.</description>
			<pubDate>Fri, 06 Dec 2024 16:21:10 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/12/241206162110.htm</guid>
		</item>
		<item>
			<title>Stopping severe malaria by harnessing natural human antibodies</title>
			<link>https://www.sciencedaily.com/releases/2024/11/241120121738.htm</link>
			<description>Scientists have identified human antibodies capable of targeting the proteins responsible for severe malaria, potentially paving the way for new vaccines or treatments. Using organ-on-a-chip technology, researchers successfully demonstrated that these antibodies prevent infected red blood cells from adhering to vessel walls, a key driver of severe malaria symptoms. The antibodies neutralize a conserved region of the malarial protein PfEMP1, overcoming its notorious variability and shedding light on acquired immunity mechanisms. This interdisciplinary study, published in Nature, highlights the power of international teamwork in addressing major health challenges like malaria.</description>
			<pubDate>Wed, 20 Nov 2024 12:17:38 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/11/241120121738.htm</guid>
		</item>
		<item>
			<title>Secrets of horse genetics for conservation, breeding</title>
			<link>https://www.sciencedaily.com/releases/2024/11/241119181604.htm</link>
			<description>Researchers are helping uncover new information about the Y chromosome in horses, which will help owners identify optimal lineages for breeding and help conservationists preserve breed diversity.</description>
			<pubDate>Tue, 19 Nov 2024 18:16:04 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/11/241119181604.htm</guid>
		</item>
		<item>
			<title>Eradivir&#039;s EV25 therapeutic reduces advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies</title>
			<link>https://www.sciencedaily.com/releases/2024/11/241119132323.htm</link>
			<description>A research article shows that Eradivir&#039;s patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.</description>
			<pubDate>Tue, 19 Nov 2024 13:23:23 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/11/241119132323.htm</guid>
		</item>
		<item>
			<title>Key influenza-severity risk factor found hiding in plain sight on our antibodies</title>
			<link>https://www.sciencedaily.com/releases/2024/11/241113123311.htm</link>
			<description>Why do some people develop severe flu symptoms? A study points the finger at an unsung portion of the antibodies our immune systems generate to fend off invading pathogens.</description>
			<pubDate>Wed, 13 Nov 2024 12:33:11 EST</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/11/241113123311.htm</guid>
		</item>
		<item>
			<title>New findings on animal viruses with potential to infect humans</title>
			<link>https://www.sciencedaily.com/releases/2024/10/241031130355.htm</link>
			<description>Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses. In a new study, researchers identified a protein in mammals that welcomes arteriviruses into host cells to start an infection. The team also found that an existing monoclonal antibody that binds to this protein protects cells from viral infection.</description>
			<pubDate>Thu, 31 Oct 2024 13:03:55 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/10/241031130355.htm</guid>
		</item>
		<item>
			<title>H5N1 virus isolated from infected dairy worker is 100% lethal in ferrets, but does not appear to be circulating in nature anymore</title>
			<link>https://www.sciencedaily.com/releases/2024/10/241028131451.htm</link>
			<description>A strain of H5N1 avian influenza virus found in a Texas dairy worker who was infected this spring was able to spread among ferrets through the air, although inefficiently, and killed 100% of infected animals in studies researchers performed with the strain earlier this year.</description>
			<pubDate>Mon, 28 Oct 2024 13:14:51 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/10/241028131451.htm</guid>
		</item>
		<item>
			<title>Maternal antibodies interfere with malaria vaccine responses</title>
			<link>https://www.sciencedaily.com/releases/2024/10/241023183620.htm</link>
			<description>Maternal antibodies passed across the placenta can interfere with the response to the malaria vaccine, which would explain its lower efficacy in infants under five months of age, according to new research. The findings suggest that children younger than currently recommended by the WHO may benefit from the RTS,S and R21 malaria vaccines if they live in areas with low malaria transmission, where mothers have less antibodies to the parasite.</description>
			<pubDate>Wed, 23 Oct 2024 18:36:20 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/10/241023183620.htm</guid>
		</item>
		<item>
			<title>Researchers identify antibodies against Klebsiella pneumoniae</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240926132129.htm</link>
			<description>Research has identified 29 novel antibodies against the bacterium Klebsiella pneumoniae, an important cause of drug-resistant infections. Using genetic and functional approaches, the researchers managed to unravel how these antibodies interact with antigens on the bacterial surface. They also found that some of these novel antibodies act synergistically to neutralize this pathogen.</description>
			<pubDate>Thu, 26 Sep 2024 13:21:29 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240926132129.htm</guid>
		</item>
		<item>
			<title>Scientists turn to human skeletons to explore origins of horseback riding</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240920165153.htm</link>
			<description>A new, wide-ranging exploration of human remains casts doubt on a long-standing theory in archaeology known as the Kurgan hypothesis -- which, among other claims, suggests that humans first domesticated horses as early as the fourth millennium B.C.</description>
			<pubDate>Fri, 20 Sep 2024 16:51:53 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240920165153.htm</guid>
		</item>
		<item>
			<title>A two-dose schedule could make HIV vaccines more effective</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240920160801.htm</link>
			<description>Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.</description>
			<pubDate>Fri, 20 Sep 2024 16:08:01 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240920160801.htm</guid>
		</item>
		<item>
			<title>Researchers discover immune response to dengue can predict risk of severe reinfections</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240920112552.htm</link>
			<description>A new study highlights the role of natural killer T cells in influencing the immune response to dengue virus, potentially reducing the severity of subsequent infections.</description>
			<pubDate>Fri, 20 Sep 2024 11:25:52 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240920112552.htm</guid>
		</item>
		<item>
			<title>Researchers discover gene variants that determine speed of graying in horses</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240919193542.htm</link>
			<description>Scientists now understand why some gray horses turn completely white as they age, while others remain an eye-catching &#039;dappled&#039; gray color.</description>
			<pubDate>Thu, 19 Sep 2024 19:35:42 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240919193542.htm</guid>
		</item>
		<item>
			<title>Are cows pickier than goats?</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240919115148.htm</link>
			<description>Linnaeus collected 643 different plant species that were then fed to horses, cows, pigs, sheep and goats. The results were carefully compiled but not analyzed until now, 275 years later.</description>
			<pubDate>Thu, 19 Sep 2024 11:51:48 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240919115148.htm</guid>
		</item>
		<item>
			<title>Monoclonal antibodies offer hope for tackling antimicrobial resistance</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240916115452.htm</link>
			<description>Monoclonal antibodies -- treatments developed by cloning a cell that makes an antibody -- could help provide an answer to the growing problem of antimicrobial resistance, say scientists.</description>
			<pubDate>Mon, 16 Sep 2024 11:54:52 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240916115452.htm</guid>
		</item>
		<item>
			<title>Promoting horse welfare with an intestinal disease screening method</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240910121042.htm</link>
			<description>Researchers are developing a promising method to support the diagnosis of inflammatory bowel diseases (IBD) in horses. Awareness of the prevalence of IBD in both humans and animals has increased in recent decades, and the need for effective and affordable diagnostic methods has become increasingly urgent.</description>
			<pubDate>Tue, 10 Sep 2024 12:10:42 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240910121042.htm</guid>
		</item>
		<item>
			<title>H5 influenza vaccines: What needs to be done to reduce the risk of a pandemic</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240904130810.htm</link>
			<description>As the global threat of H5N1 influenza looms with outbreaks across species and continents including the U.S., three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats, including to consider voluntary vaccination for those now at exposure risk.</description>
			<pubDate>Wed, 04 Sep 2024 13:08:10 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240904130810.htm</guid>
		</item>
		<item>
			<title>Rein tension may affect horse behavior</title>
			<link>https://www.sciencedaily.com/releases/2024/09/240903144416.htm</link>
			<description>High rein tension was found to be associated with trotters opening their mouths, which indicates pain or discomfort in the mouth.</description>
			<pubDate>Tue, 03 Sep 2024 14:44:16 EDT</pubDate>
			<guid isPermaLink="true">https://www.sciencedaily.com/releases/2024/09/240903144416.htm</guid>
		</item>
	</channel>
</rss>
<!-- cached Thu, 05 Mar 2026 00:59:07 EST -->